Examining the safety, feasibility and efficacy of an exercise-training program in patients awaiting a liver transplantation: a randomised controlled trial.

Mr Matthew Wallen0 sites21 target enrollmentJuly 25, 2014

Overview

No summary available.

Registry

who.int

Start Date

July 25, 2014

End Date

April 29, 2016

Last Updated

6 years ago

Study Type

Interventional

Sex

All

Sponsor

Mr Matthew Wallen

•Candidate for Liver Transplant \- as per guidelines proposed by the Transplant Society of Australia and New Zealand for Organ Transplant from Decreased Donors
•\- Gender \- males and females are eligible. The study will endeavor to recruit approximately equal numbers of males and females.
•\- Age \- Individuals aged 18 to 69 years old are eligible. At the Princess Alexandra Hospital, patients are not eligible for a liver transplant following the age of 69 years old due to organ allocation policies.
•\- Ethnicity \- All ethnic groups are eligible for the study. There is likely to be incidental recruitment of participants of Aboriginal or Torres Strait Islander ethnicity.
•\- Willingness to participate \- patients must be willing to be randomized to either the exercise intervention or usual care groups and to adhere to the protocol that they have been assigned.

•\- Patients that have previously undergone a liver transplant
•\- On transplant listing for other organs
•\- Currently smoking
•\- Any abnormality during the cardiopulmonary exercise test that indicates that it would be considered unsafe to participate in an exercise training intervention
•\- Uncontrolled diabetes mellitus
•\- Orthopaedic and/or neurological limitation to exercise as assessed by the principal investigator